JPH06197887A - Blood collecting tube - Google Patents

Blood collecting tube

Info

Publication number
JPH06197887A
JPH06197887A JP4349624A JP34962492A JPH06197887A JP H06197887 A JPH06197887 A JP H06197887A JP 4349624 A JP4349624 A JP 4349624A JP 34962492 A JP34962492 A JP 34962492A JP H06197887 A JPH06197887 A JP H06197887A
Authority
JP
Japan
Prior art keywords
blood
pellet
collection tube
specific gravity
binder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4349624A
Other languages
Japanese (ja)
Other versions
JP2734918B2 (en
Inventor
Yoichi Tsukagoshi
要一 塚越
Toshimasa Yamamoto
俊昌 山本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIIGATA KAKO KK
Original Assignee
NIIGATA KAKO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIIGATA KAKO KK filed Critical NIIGATA KAKO KK
Priority to JP4349624A priority Critical patent/JP2734918B2/en
Publication of JPH06197887A publication Critical patent/JPH06197887A/en
Application granted granted Critical
Publication of JP2734918B2 publication Critical patent/JP2734918B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To completely congeal extracted blood by setting a pellet formed of particulate cores having a specific gravity which is intermediate between those of blood serums and blood corpuscles and having outer surfaces each formed thereon with a sticking layer made of a material in which a powder-like blood coagulant is dispersed in a water-soluble and blood-inactive binder, on the inner surface of a blood collecting tube. CONSTITUTION:A blood collecting tube 1 is composed of a plastic tube body 2 and an elastic cap 2a. A pellet 3 is set on the inner surface of the tube body 2. The pellet 3 is made of plastic materials, formed of small spherical cores 4 having a specific gravity which is intermediate between those of blood serums and blood corpuscles and having outer surfaces each covered thereover with a sticking layer 6 in which a fine powder-like blood coagulant 5 is dispersed in a binder which is water-soluble and is inactive to blood. The cores 4 preferably has a specific gravity of 1.04 to 1.055 and a particle size of 0.05 to 1.0mm, and is made of polystyrene, ABS resin or the like. The blood coagulant 5 is made of fine powder of glass or silica, and the binder is made of water-soluble silicone or polyethylene glycol or the like. Thereby it is possible to easily and surely congeal collected blood.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、血液検体を遠心分離操
作によって血清と血餅に分離する際などに用いられる採
血管に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a blood collection tube used for separating a blood sample into serum and blood clot by centrifugation.

【0002】[0002]

【従来の技術】血液検査に際し、採血された血液は遠心
分離して血清と血球成分(血餅)とに分離するが、血液
検体は遠心分離する前に充分に凝固させておく必要があ
る。凝固が不充分であると遠心分離後に、僅かの衝撃で
血球が舞い上がって血清層に混入したり、また血清層中
にフィブリンが発生して血清を用いる検査に支障を来す
ことになる。従来、血液検査の迅速化、効率化に鑑み、
血液検体の凝固を促進させるための材料および方法が種
々提案されている。このような血液凝固促進のための第
1の方法として、ガラス粉末を採血管の底に入れておく
方法がある。この方法では、血液凝固促進の効果を持た
せるため、及び血液中への良好な分散を得るために極め
て微細なガラス粉末が必要となる。
2. Description of the Related Art In a blood test, the collected blood is centrifuged to separate it into serum and blood cell components (blood clots), but a blood sample must be sufficiently coagulated before centrifugation. If the coagulation is not sufficient, after centrifugation, blood cells will float up and enter the serum layer with a slight impact, or fibrin will be generated in the serum layer, which will interfere with the test using serum. Conventionally, in view of the speed and efficiency of blood tests,
Various materials and methods have been proposed for promoting the coagulation of blood samples. As a first method for promoting such blood coagulation, there is a method of putting glass powder in the bottom of a blood collection tube. This method requires extremely fine glass powder in order to have the effect of promoting blood coagulation and to obtain good dispersion in blood.

【0003】血液凝固促進のための第2の方法として、
特公昭59−6655号公報に記載された採血管を用い
る方法がある。この採血管は、プラスチック製採血管の
内表面に、血液成分と付着しにくい物質にガラス粉末な
どの血液凝固促進剤を分散させた材料を塗布したもので
あり、採血管内に血液を入れて放置した時に、血餅を主
とする血液成分が管壁に付着することなく血餅収縮が行
われ、ガラス製採血管と同様に血液凝固を進行させるも
のである。
As a second method for promoting blood coagulation,
There is a method using a blood collection tube described in JP-B-59-6655. This blood collection tube is a plastic blood collection tube with an inner surface coated with a material in which a blood coagulation promoter, such as glass powder, is dispersed in a substance that does not easily adhere to blood components. At this time, the blood component mainly composed of the blood clot is contracted without adhering to the tube wall, and the blood coagulation is promoted like the glass blood collection tube.

【0004】血液凝固促進のための第3の方法として、
特公昭58−27933号公報に記載された採血管を用
いる方法がある。この採血管は、管内に、血球より高比
重の担体に、血清に可溶性のバインダーを介して粉状血
液凝固促進剤を担持させたものであり、採血管内に血液
を入れると、バインダーの溶解につれて血液凝固促進剤
が血液中に分散し、凝固促進効果が得られるようになっ
ている。
As a third method for promoting blood coagulation,
There is a method using a blood collection tube described in JP-B-58-27933. This blood collection tube is a carrier having a specific gravity higher than that of blood cells, and a powdery blood coagulation promoter supported on the carrier through a serum-soluble binder.When blood is put into the blood collection tube, the binder is dissolved as it is dissolved. A blood coagulation promoter is dispersed in blood to obtain a coagulation promoting effect.

【0005】[0005]

【発明が解決しようとする課題】しかしながら、これら
従来技術には次のような問題があった。上記第1の方法
は、ガラス粉末によって血球が破壊されるおそれがあ
り、また、少量の粉末であるために採血管を使用前に逆
にしたり振ると、粉末がキャップに付着したり、血液に
触れない採血管上部内壁に付着して離れなくなる場合が
あった。また上記第2の方法は、血液成分と付着しにく
い物質にガラス粉末などの血液凝固促進剤を分散させた
材料を採血管内に塗布する工程やそれを乾燥させる工程
に手間がかかり、また材料を塗布した跡が汚く外観を損
ねること、さらに実際上血液を注入した後、凝固促進剤
の分散をよくするために、採血管を5〜6回軽く振る
(転倒混和する)必要がある。さらに上記第3の方法
は、血液より高比重の担体を用いることにより、凝固促
進剤の分散性が悪く、また遠心分離時にこの担体が血餅
を押し込んで管底に到達する際に血球を破壊するおそれ
がある。
However, these conventional techniques have the following problems. In the first method, the blood cells may be destroyed by the glass powder, and since the blood collection tube is a small amount of powder, if the blood collection tube is inverted or shaken before use, the powder adheres to the cap or the blood. There was a case where it adhered to the inner wall of the upper part of the blood collection tube that was not touched and could not be separated. In the second method, it takes time and effort to apply a material in which a blood coagulation promoter, such as glass powder, is dispersed in a substance that does not easily adhere to blood components to the blood collection tube or to dry the material, and It is necessary to shake the blood collection tube 5 to 6 times (mix by overturning) in order to make the traces of application dirty and impair the appearance, and to actually improve the dispersion of the coagulation accelerator after injecting blood. Furthermore, the third method uses a carrier having a higher specific gravity than that of blood, so that the dispersibility of the coagulation promoter is poor, and the carrier pushes the clot during centrifugation and destroys blood cells when reaching the bottom of the tube. May occur.

【0006】本発明は上記事情に鑑みてなされたもの
で、血液の凝固を迅速にしかも確実に行うことのできる
採血管の提供を目的としている。
The present invention has been made in view of the above circumstances, and an object thereof is to provide a blood collection tube capable of rapidly and reliably coagulating blood.

【0007】[0007]

【課題を解決するための手段】本発明は、血清と血球の
中間の比重を有する粒状の芯材の表面に、粉末状の血液
凝固促進剤を水溶性でかつ血液に不活性なバインダーに
分散させた材料よりなる付着層を形成してなるペレット
を、管本体内に収容したことを特徴とする採血管であ
る。また、上記芯材の粒径は、0.05mm〜1.0mm
とすることが望ましい。
According to the present invention, a powdery blood coagulation promoter is dispersed in a water-soluble and blood-inert binder on the surface of a granular core material having a specific gravity intermediate between serum and blood cells. A blood collection tube is characterized in that a pellet formed by forming an adhesion layer made of the selected material is housed in a tube body. Further, the particle diameter of the core material is 0.05 mm to 1.0 mm.
Is desirable.

【0008】[0008]

【作用】上記ペレットは、血清と血球の中間の比重を有
する粒状の芯材の表面に、粉末状の血液凝固促進剤を水
溶性でかつ血液に不活性なバインダーに分散させた材料
よりなる付着層を形成してなるものなので、採血管に血
液検体を注入すると、このペレットが舞い上がって血液
中に均一に分散し、ペレット表面の付着層中のバインダ
ーが血液中に溶解し、粉末状の血液凝固促進剤が血液中
に放出されて均一に分散し、血液の凝固を促進させる。
ペレットの芯材は、遠心分離の際に、分離した血清と血
餅との境界に集合し、血清の分取の妨げにならない。
The above pellets are adhered to the surface of a granular core material having a specific gravity between serum and blood cells, which is made of a material in which a powdery blood coagulation promoter is dispersed in a water-soluble and blood-inert binder. Since a blood sample is injected into the blood collection tube, this pellet rises up and is evenly dispersed in the blood, and the binder in the adhesion layer on the surface of the pellet dissolves in the blood to form a powdered blood sample. The coagulation accelerator is released into the blood and is uniformly dispersed to promote the coagulation of the blood.
During centrifugation, the pellet core material gathers at the boundary between the separated serum and blood clot and does not hinder the separation of serum.

【0009】[0009]

【実施例】図1は本発明の採血管の一実施例を示すもの
である。この採血管1は、プラスチック製の採血管本体
2内に、血液凝固促進剤を含んだ粒状のペレット3を収
容して構成されている。この図1に示す実施例ではペレ
ット3どうしが凝集して団子状になって採血管本体2の
底面に付着しているが、ペレット3の収容状態はこれに
限らず、わずかの衝撃や管を逆さにした時等にペレット
3が離れない程度に、管の底部や内壁に薄く付着させて
も良い。また管本体2の上部開口にはキャップ2aが装
着されている。
FIG. 1 shows an embodiment of a blood collection tube according to the present invention. This blood collection tube 1 is configured by accommodating a granular pellet 3 containing a blood coagulation promoter in a plastic blood collection tube body 2. In the embodiment shown in FIG. 1, the pellets 3 are aggregated and formed into a dumpling-like shape and attached to the bottom surface of the blood collection tube main body 2. However, the accommodation state of the pellets 3 is not limited to this, and a slight impact or tube The pellet 3 may be thinly attached to the bottom or inner wall of the tube so that the pellet 3 does not separate when inverted. A cap 2a is attached to the upper opening of the tube body 2.

【0010】このペレット3は図2に示すように、プラ
スチック製の小球状の芯材4の表面に、微粉末状の血液
凝固促進剤5を水溶性でかつ血液に不活性なバインダー
に分散させた材料よりなる付着層6を被覆して構成され
ている。この芯材4は、血清と血餅の中間の比重、即ち
比重が1.04〜1.055の範囲であり、かつその粒径
は0.05mm〜1.0mmの範囲とするのが望ましい。
芯材4の比重が上記範囲以外であると、凝固血液を遠心
分離する際に、この芯材が血清層の上に浮上して血清の
サンプリングの妨げとなり、あるいは血餅層の下に沈降
して血餅を押して血球の破壊を招いてしまう。芯材4の
比重を上記範囲内とすれば、血液注入時にペレット3が
血液中に均一に分散するとともに、凝固血液を遠心分離
する際に、芯材4が血清層と血餅層の中間に集合する。
このような比重を有する材料としては、ポリスチレン樹
脂、ABS樹脂などであり、さらにポリエチレンやポリ
プロピレンなどに充填材を混和して比重を調整した材料
などを使用することができる。また、芯材4の粒径が
0.05mmより小さいと、ペレットどうしの凝集が生
じ易くなり、血液を注入した時に分散し難くなるととも
に、採血管を逆にしたり傾けた時にペレットが、血液検
体と接しないキャップや管本体の上部内壁面に付着して
落下しなくなるおそれがある。一方、芯材4の粒径が
1.0mmより大きいと、血液中への分散性が悪化す
る。
As shown in FIG. 2, the pellet 3 has a surface of a plastic small spherical core 4 on which a fine powdery blood coagulation promoter 5 is dispersed in a water-soluble and blood-inert binder. It is configured by covering the adhesion layer 6 made of the above material. The core material 4 preferably has a specific gravity between serum and blood clot, that is, a specific gravity in the range of 1.04 to 1.055, and a particle size in the range of 0.05 mm to 1.0 mm.
When the specific gravity of the core material 4 is out of the above range, when the coagulated blood is centrifuged, the core material floats above the serum layer and hinders the sampling of serum, or it sediments below the blood clot layer. Press the blood clot and destroy the blood cells. When the specific gravity of the core material 4 is within the above range, the pellet 3 is uniformly dispersed in blood during blood injection, and the core material 4 is placed between the serum layer and the blood clot layer when the coagulated blood is centrifuged. Gather.
As a material having such a specific gravity, polystyrene resin, ABS resin, or the like, and a material in which a specific gravity is adjusted by mixing a filler with polyethylene, polypropylene, or the like can be used. When the particle diameter of the core material 4 is smaller than 0.05 mm, the pellets are likely to aggregate with each other, which makes it difficult to disperse the blood when it is injected. There is a risk that it will not come into contact with the cap or the inner wall surface of the upper part of the pipe body that does not come into contact with it and will not fall. On the other hand, when the particle diameter of the core material 4 is larger than 1.0 mm, the dispersibility in blood deteriorates.

【0011】この芯材4の表面に被覆形成された付着層
6は、微粉末状の血液凝固促進剤5を水溶性でかつ血液
に不活性なバインダーに分散させた材料よりなってい
る。この血液凝固促進剤5としては、ガラス微粉末、シ
リカ微粉末、珪藻土などの無機材料微粉末が好適に用い
られる。また、バインダーとしては、水溶性シリコー
ン、ポリエチレングリコール、デキストラン、ポリビニ
ルピロリドンなどが好適に用いられる。
The adhesion layer 6 formed on the surface of the core material 4 is made of a material in which a fine powdery blood coagulation promoter 5 is dispersed in a water-soluble and blood-inert binder. As the blood coagulation promoter 5, fine powder of inorganic material such as glass fine powder, silica fine powder and diatomaceous earth is preferably used. As the binder, water-soluble silicone, polyethylene glycol, dextran, polyvinylpyrrolidone, etc. are preferably used.

【0012】このペレット3は、例えば、バインダーに
エタノールなどの溶媒を加えて溶解し、その溶液に血液
凝固促進剤を加えて均一に分散させておき、これに芯材
を浸漬して乾燥するだけで容易に作製できる。ペレット
当りの血液凝固促進剤の付着量、及び採血管1本当りの
ペレット収容量は特に限定されないが、採血管1本当り
の血液凝固促進剤の添加量が1〜5mg程度となり、ま
た採血管1本当りのペレットの収容量が0.05〜0.5
g程度となるように設定するのが望ましい。
The pellet 3 is dissolved, for example, by adding a solvent such as ethanol to a binder, adding a blood coagulation accelerating agent to the solution and uniformly dispersing it, and immersing the core material in the solution to dry it. Can be easily manufactured. The amount of blood coagulation promoter adhering to the pellet and the amount of pellets accommodated in each blood collection tube are not particularly limited, but the amount of blood coagulation promoter added per blood collection tube is about 1 to 5 mg. The capacity of each pellet is 0.05-0.5
It is desirable to set it to be about g.

【0013】図3ないし図6は、上記ペレット3を備え
た採血管1を用いた血液の分離操作を説明するためのも
のである。図3に示すように、採血した血液を、キャッ
プを外した採血管1の管本体2内に注入すると、管本体
2に収容されたペレット3は、あたかも舞い上がるが如
く血液7中に分散される。そして、図4に示すように、
注入血液7にペレット3が分散されるとともに、ペレッ
ト3表面の付着層6に含まれるバインダーが血液7中に
溶け出することにより、付着層6中の血液凝固促進剤5
が血液7中に放出され、血液7を注入する時の乱流で血
液7の全領域に均一に分散される。従って、血液凝固促
進剤5を均一に分散させるために、採血管を転倒混和し
たり振り混ぜることなく、管本体2内に血液7を注入す
るだけで極めて均一に血液凝固促進剤5を分散させるこ
とが可能となる。
FIGS. 3 to 6 are for explaining a blood separating operation using the blood collection tube 1 having the pellet 3. As shown in FIG. 3, when the collected blood is injected into the tube body 2 of the blood collection tube 1 with the cap removed, the pellet 3 accommodated in the tube body 2 is dispersed in the blood 7 as if it were rising. . Then, as shown in FIG.
The pellet 3 is dispersed in the infused blood 7 and the binder contained in the adhesive layer 6 on the surface of the pellet 3 is dissolved into the blood 7 to form the blood coagulation promoter 5 in the adhesive layer 6.
Are released into the blood 7 and are evenly dispersed in the whole area of the blood 7 by the turbulent flow when the blood 7 is injected. Therefore, in order to disperse the blood coagulation promoting agent 5 uniformly, the blood coagulation promoting agent 5 is extremely evenly dispersed only by injecting the blood 7 into the tube body 2 without inverting or mixing the blood collection tube. It becomes possible.

【0014】ついで、管本体2を静置して血液7を凝固
させる。血液の凝固は、血液凝固促進剤5を血液の全領
域に均一に分散させたことにより、より速やかに起こ
り、血液は図5に示すように凝固し、血清8と血餅9と
が容易に分離可能な状態となる。ついで、これを遠心分
離することによって、図6に示すように、血清8と血餅
9とが完全に分離する。その際、ペレット3の残部であ
る芯材4は、血清と血餅との中間の比重を有しているこ
とから、血清8と血餅9との中間に集合し、血清8のサ
ンプリングの妨げとならない。
Then, the tube body 2 is allowed to stand still to coagulate the blood 7. The coagulation of blood occurs more quickly because the blood coagulation promoter 5 is uniformly dispersed in all areas of the blood, and the blood coagulates as shown in FIG. 5, so that the serum 8 and the blood clot 9 are easily formed. It becomes separable. Then, by centrifuging this, the serum 8 and the blood clot 9 are completely separated as shown in FIG. At that time, since the core material 4 which is the rest of the pellet 3 has a specific gravity intermediate between the serum and the blood clot, it gathers in the intermediate between the serum 8 and the blood clot 9 and hinders the sampling of the serum 8. It does not become.

【0015】(実験例)採血管本体はポリプロピレン製
の容量が10mlのものを用いた。血液凝固促進剤は、
高純度合成球状シリカ((株)龍森製 アドマファイン
SO−C3、平均粒径0.85μm)を用いた。バイン
ダーにはポリエチレングリコール#300を用いた。ペレ
ット芯材は積水化成社製のポリスチレンペレット(MS
−171 比重1.05、粒径0.4〜0.2mm)を用
いた。シリカ10g、ポリエチレングリコール25g、
エタノール465gを混合した液を作製し、この液中に
芯材750gを投入した。80℃の温度で約20分間乾
燥しエタノールを飛散させてペレットを作製した。この
ペレットをガラスの採血管に少量入れ、水を少しづつ管
壁を伝って注入すると、管底で団子状に凝集していたペ
レットが、極めて容易に個々のペレットに別れ、水流に
よって水中に舞い上がり、ペレットに付着していたシリ
カが速やかに水中に分散していくのが観察された。
(Experimental example) The main body of the blood collection tube was made of polypropylene and had a capacity of 10 ml. Blood coagulation promoters
High-purity synthetic spherical silica (manufactured by Tatsumori Co., Ltd. Admafine SO-C3, average particle size 0.85 μm) was used. Polyethylene glycol # 300 was used as the binder. Pellet core material is polystyrene pellets (MS
-171 specific gravity of 1.05 and a particle size of 0.4 to 0.2 mm) were used. 10 g of silica, 25 g of polyethylene glycol,
A liquid was prepared by mixing 465 g of ethanol, and 750 g of the core material was put into this liquid. It was dried at a temperature of 80 ° C. for about 20 minutes and ethanol was scattered to prepare pellets. If you put a small amount of this pellet in a glass blood collection tube and inject water little by little along the tube wall, the pellets that had aggregated in a dumpling at the bottom of the tube were very easily separated into individual pellets, and the water flowed up into the water. It was observed that the silica adhering to the pellet rapidly dispersed in water.

【0016】上記ペレットを0.23g計り取りポリプ
ロピレン製採血管内に入れた。この0.23gのペレッ
トには約3mgのシリカが付着している計算になる。採
血管に入れたペレットは、管底で団子状に相互に付着し
ており、管を振り回しても移動せず安定していた。この
ペレットを入れた採血管内に血液を7ml注入した。血
液注入後2時間の観察では、凝固が充分であり血餅の縮
退も進んでいることが判った。ついで、これを1000
G×10分間遠心分離したところ、血清と血餅が完全に
分離した。遠心分離した血清を小さい匙で攪拌してフィ
ブリン発生の有無を調べたが、血清中にフィブリンは発
生しておらず、血液凝固が完全であったことが確認され
た。
0.26 g of the above pellet was weighed and placed in a polypropylene blood collection tube. It is calculated that about 3 mg of silica is attached to the pellet of 0.23 g. The pellets put in the blood collection tube adhered to each other in a dumpling-like manner at the bottom of the tube and were stable without shaking even when the tube was swung. 7 ml of blood was injected into the blood collection tube containing the pellet. Observation 2 hours after the blood injection revealed that the coagulation was sufficient and the clot was degenerated. Then this is 1000
After centrifugation for G × 10 minutes, serum and blood clot were completely separated. The centrifuged serum was stirred with a small spoon to examine the presence or absence of fibrin generation. It was confirmed that fibrin did not occur in the serum and blood coagulation was complete.

【0017】(比較例)実験例と同じポリプロピレン採
血管に約7mlび血液を注入した。但しこの比較例では
採血管に凝固促進処理は施さなかった。2時間放置した
後に1000G×10分間遠心分離を行ったところ、一
応血清と血餅とに分離されたが、血清中に糸状のフィブ
リンが発生していた。また血餅層は凝固が完全でなく、
液状の血球液が多量に残っていた。さらに、血清からフ
ィブリンを取り除き、小さなガラス容器に移し、匙で攪
拌したらフィブリンが発生し、匙に絡みついた。
Comparative Example About 7 ml of blood was injected into the same polypropylene blood collection tube as in the experimental example. However, in this comparative example, the blood collection tube was not subjected to coagulation accelerating treatment. When it was left for 2 hours and then centrifuged at 1000 G for 10 minutes, it was once separated into serum and blood clot, but filamentous fibrin was found in the serum. Also, the clot layer is not completely coagulated,
A large amount of liquid blood cells remained. Furthermore, the fibrin was removed from the serum, transferred to a small glass container, and stirred with a spoon to generate fibrin, which was entangled in the spoon.

【0018】[0018]

【発明の効果】以上説明したように、本発明の採血管
は、血清と血球の中間の比重を有する材料からなる粒状
の芯材の表面に、粉末状の血液凝固促進剤を水溶性でか
つ血液に不活性なバインダーに分散させた材料の付着層
を形成してなるペレットを、管本体の内壁に存在させた
ものなので、この採血管に血液検体を注入すると、この
ペレットが血液中に均一に分散され、ペレット表面の付
着層中のバインダーが血液中に溶解し、粉末状の血液凝
固促進剤が血液中に放出されて均一に分散し、血液の凝
固を促進させ、短時間で完全に血液凝固を行うことがで
きる。従って本発明の採血管は血液を注入するだけで血
液凝固促進剤を均一に分散させることができて取扱いが
容易であり、しかも血液の凝固を完全かつ確実に行うこ
とができる。
As described above, in the blood collection tube of the present invention, a powdery blood coagulation promoter is water-soluble and is formed on the surface of a granular core material made of a material having a specific gravity intermediate between serum and blood cells. A pellet formed by forming an adhesion layer of a material dispersed in a binder inert to blood is present on the inner wall of the tube body, so when a blood sample is injected into this blood collection tube, this pellet becomes uniform in the blood. , The binder in the adhesion layer on the pellet surface is dissolved in blood, and the powdery blood coagulation promoter is released into the blood and evenly dispersed, promoting blood coagulation and completely completing in a short time. Can perform blood coagulation. Therefore, in the blood collection tube of the present invention, the blood coagulation promoter can be uniformly dispersed just by injecting blood, and it is easy to handle, and further, blood coagulation can be completely and surely performed.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の採血管の一実施例を示す正面断面図で
ある。
FIG. 1 is a front sectional view showing an embodiment of a blood collection tube of the present invention.

【図2】同じ採血管に用いられたペレットを一部断面視
した拡大図である。
FIG. 2 is an enlarged view in which a pellet used in the same blood collection tube is partially sectioned.

【図3】本発明の採血管の血液分離操作を説明するため
の図であって、血液注入状態を示す概略図である。
FIG. 3 is a view for explaining the blood separation operation of the blood collection tube of the present invention, and is a schematic view showing a blood injection state.

【図4】同じく血液注入終了後の状態を示す概略図であ
る。
FIG. 4 is a schematic view showing a state after completion of blood injection.

【図5】同じく凝固終了状態を示す概略図である。FIG. 5 is a schematic view showing a coagulation completion state.

【図6】同じく遠心分離終了状態を示す概略図である。FIG. 6 is a schematic view showing a state where centrifugation has been completed.

【符号の説明】[Explanation of symbols]

1……採血管、2……管本体、3……ペレット、4……
芯材、5……血液凝固促進剤、6……付着層、7……血
液、8……血清、9……血餅。
1 ... Blood collection tube, 2 ... Tube body, 3 ... Pellet, 4 ...
Core material, 5 ... Blood coagulation promoter, 6 ... Adhesive layer, 7 ... Blood, 8 ... Serum, 9 ... Blood clot.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 血清と血球の中間の比重を有する粒状の
芯材の表面に、粉末状の血液凝固促進剤を水溶性でかつ
血液に不活性なバインダーに分散させた材料よりなる付
着層を形成してなるペレットを、管本体内の内壁に存在
させたことを特徴とする採血管。
1. An adhesion layer made of a material in which a powdery blood coagulation promoter is dispersed in a water-soluble and blood-inactive binder on the surface of a granular core material having a specific gravity intermediate between serum and blood cells. A blood collection tube in which the formed pellet is present on the inner wall of the tube body.
【請求項2】 上記芯材の粒径を0.05mm〜1.0m
mとしたことを特徴とする請求項1の採血管。
2. The particle size of the core material is 0.05 mm to 1.0 m.
The blood collection tube according to claim 1, wherein the blood collection tube is m.
JP4349624A 1992-12-28 1992-12-28 Blood collection tube Expired - Lifetime JP2734918B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4349624A JP2734918B2 (en) 1992-12-28 1992-12-28 Blood collection tube

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4349624A JP2734918B2 (en) 1992-12-28 1992-12-28 Blood collection tube

Publications (2)

Publication Number Publication Date
JPH06197887A true JPH06197887A (en) 1994-07-19
JP2734918B2 JP2734918B2 (en) 1998-04-02

Family

ID=18405001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4349624A Expired - Lifetime JP2734918B2 (en) 1992-12-28 1992-12-28 Blood collection tube

Country Status (1)

Country Link
JP (1) JP2734918B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744027A1 (en) * 1986-12-29 1988-07-07 Smc Corp ELECTRICAL FEEDING DEVICE FOR SOLENOID VALVES
JPH08299309A (en) * 1995-04-28 1996-11-19 Becton Dickinson & Co Blood-gathering assembly containing glass insertion member for coagulation promotion
US5833630A (en) * 1994-11-03 1998-11-10 Kloth; Bernd Sample collection device
JP2007185534A (en) * 2003-05-21 2007-07-26 Jms Co Ltd Container for serum production and method of regenerative medicine using the same
EP2334307A1 (en) * 2008-08-22 2011-06-22 Reapplix APS Multilayered blood product
US8796017B2 (en) 2003-05-21 2014-08-05 Jms Co., Ltd. Container for preparing serum and regenerative medical process using the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5266621A (en) * 1975-11-29 1977-06-02 Terumo Corp Serum or plasma separating composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5266621A (en) * 1975-11-29 1977-06-02 Terumo Corp Serum or plasma separating composition

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744027A1 (en) * 1986-12-29 1988-07-07 Smc Corp ELECTRICAL FEEDING DEVICE FOR SOLENOID VALVES
US4815496A (en) * 1986-12-29 1989-03-28 Smc Corporation Power feeder for solenoid valves
US5833630A (en) * 1994-11-03 1998-11-10 Kloth; Bernd Sample collection device
JPH08299309A (en) * 1995-04-28 1996-11-19 Becton Dickinson & Co Blood-gathering assembly containing glass insertion member for coagulation promotion
JP2007185534A (en) * 2003-05-21 2007-07-26 Jms Co Ltd Container for serum production and method of regenerative medicine using the same
US8796017B2 (en) 2003-05-21 2014-08-05 Jms Co., Ltd. Container for preparing serum and regenerative medical process using the same
US8993321B2 (en) 2003-05-21 2015-03-31 Jms Co., Ltd. Container for preparing serum and regenerative medical process using the same
EP2334307A1 (en) * 2008-08-22 2011-06-22 Reapplix APS Multilayered blood product
EP2334307A4 (en) * 2008-08-22 2011-11-02 Reapplix Aps Multilayered blood product
US8980301B2 (en) 2008-08-22 2015-03-17 Reapplix Aps Multilayered blood product
US10933095B2 (en) 2008-08-22 2021-03-02 Reapplix Aps Multilayered blood product

Also Published As

Publication number Publication date
JP2734918B2 (en) 1998-04-02

Similar Documents

Publication Publication Date Title
JP2961056B2 (en) Blood collection assembly including procoagulant plastic insert
EP0744026B1 (en) Separator float for blood collection tubes
EP2704841B1 (en) Method and insert for density gradient separation
US5736033A (en) Separator float for blood collection tubes with water swellable material
US4189382A (en) Blood coagulation and separation
JP2866803B2 (en) Two-way clotting accelerator for blood collection tubes
JPH07378A (en) Tube with unitary blood coagulation activating substance and its production
JPH06197887A (en) Blood collecting tube
JPS6314782B2 (en)
JPS6367660B2 (en)
JP3514848B2 (en) Blood test container
JP2000292421A (en) Blood treatment method and blood-samping tube
JPH02167140A (en) Blood-collecting tube and blood testing method using the same
JP3292760B2 (en) Blood collection tube and method for producing the same
JPH11114995A (en) Method for injection molding to form product with container melt coated on inner surface
JP2819325B2 (en) Sample tube
JP3851442B2 (en) Blood coagulation promoter and blood test container
JP2001269328A (en) Blood drawing tube
JPS58105063A (en) Vessel for blood inspection
JPS6367862B2 (en)
JPH04146727A (en) Blood separating agent filling body
JPH07294514A (en) Blood coagulation accelerating agent and separation of serum from blood using the same
JPH0126505B2 (en)
JP2000262499A (en) Blood collecting tube
JPS62148647A (en) Blood sampling tube having blood coagulating action

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19971202